Press release
Ankylosing Spondylitis Global Market to See Booming Growth 2024-2033 | Pfizer Inc., AbbVie Inc., Novartis AG, Eli Lilly and Company, Gilead Sciences Inc.
Ankylosing Spondylitis Global Market
The Business Research Company presents an extensive market research report on the Ankylosing Spondylitis Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.
Market Sizing:
The ankylosing spondylitis market size has grown strongly in recent years. It will grow from $5.41 billion in 2023 to $5.86 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to hla-b27 discovery, biologic treatments development, pain management approaches, patient advocacy and awareness, nsaids and disease modifying drugs.
The ankylosing spondylitis market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to personalized medicine approach, novel biologics development, early intervention and screening, lifestyle and diet management, telemedicine and remote monitoring. Major trends in the forecast period include biosimilar availability, targeted pain therapies, patient-reported outcomes (pros) emphasis, community support programs, regenerative medicine exploration.
Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp
Key Market Players:
Major companies operating in the ankylosing spondylitis market report are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., Regeneron Pharmaceuticals Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Sandoz International GmbH, Reliance Life Sciences Pvt. Ltd., Affibody Medical AB
Market Drivers:
The increasing geriatric population is expected to propel the growth of the ankylosing spondylitis market going forward. The geriatric population refers to an increase in the proportion of elderly people due to changes in the age structure of a population. This demographic shift has increased the number and proportion of people over the age of 60. Ankylosing spondylitis treatment and drugs help to improve mobility and manage pain in the geriatric population having ankylosing spondylitis condition. For instance, in October 2022, according to World Health Organization, a Switzerland-based international public health organization, by 2030, 1 out of 6 people in the world will be aged more than 60 years or above, and in 2020, there was a rise in 1 billion aged people reaching to 1.4 billion. Therefore, the increasing geriatric population is driving the growth of the ankylosing spondylitis market.
Learn More About The Market Report -
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report
The ankylosing spondylitis market covered in this report is segmented -
1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users
The report answers the following questions:
What are the primary factors propelling the market during the projected period?
In which region is the most substantial growth expected?
Which trend will take center stage in the upcoming period?
Want To Know More About The Business Research Company?
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ankylosing Spondylitis Global Market to See Booming Growth 2024-2033 | Pfizer Inc., AbbVie Inc., Novartis AG, Eli Lilly and Company, Gilead Sciences Inc. here
News-ID: 3380414 • Views: …
More Releases from The Business research company
Market Trend Insights: The Impact of Recent Advances on the Plasma Pyrolysis Hyd …
The plasma pyrolysis hydrogen market is positioned for remarkable expansion in the coming years, driven by growing environmental consciousness and technological innovations. This emerging sector offers promising solutions to meet the increasing demand for clean energy by utilizing advanced plasma pyrolysis methods. Let's explore the current market size, key players, influential trends, and segmentation to understand the dynamics shaping this industry.
Projected Growth and Size of the Plasma Pyrolysis Hydrogen Market
The…
Trends in Growth, Market Segmentation, and Competitive Approaches Influencing th …
The patient data hub solutions sector is set to experience remarkable expansion in the coming years, driven by technological advancements and evolving healthcare needs. This market plays a crucial role in improving patient care by enabling better data management and analytics. Let's explore its current market value, key players, emerging trends, and the various segments defining this growing industry.
Expected Market Size and Growth Trajectory of the Patient Data Hub Solutions…
Analysis of Key Market Segments Influencing the Optical Transport Network (OTN) …
The optical transport network (OTN) hardware sector is positioned for significant growth as demand for faster and more efficient data transmission continues to rise. With rapid technological advancements and increasing integration of next-generation networks, the market is becoming a critical pillar for supporting digital infrastructure worldwide. Let's explore the current market size, key players, influential trends, and industry segments shaping the future of OTN hardware.
Projected Market Value and Growth Drivers…
Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influenci …
The multi-fiber push on (MPO) or mechanical transfer push-on (MTP) cabling assemblies market is on track for significant expansion in the coming years, driven by advancements in data transmission technology and increasing demand for efficient connectivity solutions. As digital transformation accelerates across industries, these cabling assemblies are becoming essential components in modern network infrastructure. Below is a detailed overview of the market's size, key drivers, leading players, trends, and main…
More Releases for Ankylosing
Ankylosing Spondylitis Market Trends That Will Shape the Next Decade: Insights f …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Ankylosing Spondylitis Market Size By 2025?
The valuation of the ankylosing spondylitis sector has experienced robust expansion over the past few years, projected to advance from a figure of $5.9 billion in the year 2024 up to $6.34 billion by 2025, reflecting a compound annual…
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate?
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638
Introduction:
The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively.
Unveiling Ankylosing…
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.…
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/
Retail Pharmacy to Dominate the…
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631
Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen…
